Zevra Therapeutics
ZVRA
29 hedge funds and large institutions have $1.97M invested in Zevra Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
7% more funds holding
Funds holding: 27 → 29 (+2)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
36% less capital invested
Capital invested by funds: $3.09M → $1.97M (-$1.12M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
+$138K |
| 2 |
Renaissance Technologies
New York
|
+$59K |
| 3 |
RFN
RDA Financial Network
Akron,
Iowa
|
+$57.1K |
| 4 |
Jane Street
New York
|
+$12.2K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$10.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
-$47K |
| 2 |
DM
Deerfield Management
New York
|
-$34.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$16K |
| 4 |
CW
CreativeOne Wealth
Overland Park,
Kansas
|
-$10K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.58K |
ZVRA Hedge Fund Activity: Q1 2020 in Review
29 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Zevra Therapeutics (ZVRA) for Q1 2020, worth a combined $1.97M — down 36% from $3.09M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ZVRA positions and 5 closed out — a net gain of 4 holders — while 6 added to existing stakes and 7 trimmed.
The largest buyer was Banco Bilbao Vizcaya Argentaria, opening a new position worth an estimated $138K. The largest seller was Wedbush Securities, exiting entirely with an estimated $47K sold.
- 29 institutional investors held Zevra Therapeutics (ZVRA) as of Q1 2020, up from 27 in Q4 2019.
- Funds reported $1.97M of Zevra Therapeutics stock for Q1 2020, down 36% quarter-over-quarter.
- 9 funds opened new Zevra Therapeutics positions in Q1 2020 and 5 closed out, a net change of +4 holders.
- The largest Zevra Therapeutics buyer in Q1 2020 was Banco Bilbao Vizcaya Argentaria, an estimated $138K added.
- The largest Zevra Therapeutics seller in Q1 2020 was Wedbush Securities, an estimated $47K sold.
Based on aggregated 13F filings for Q1 2020.